Advanced Enzyme Technologies Ltd Financial Statements & Historical Data

Updated NSE: ADVENZYMESBSE: 540025
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 28 September 2026, 8:04 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price283₹ per share
Reported P/E20.1Times
Book value per share146₹ per share
Reported ROCE14.0 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 28 September 2026, 8:04 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap3,167 Cr.
Current Price283
High / Low420/252
Stock P/E20.1
Book Value146
Dividend Yield1.89 %
ROCE14.0 %
ROE10.2 %
Face Value2.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Advanced Enzyme Technologies Ltd 3,167 Cr. 283 420/25220.1 1461.89 %14.0 %10.2 % 2.00
Ind-Swift Laboratories Ltd 3,547 Cr. 408 420/87.054.5 1590.00 %4.86 %4.02 % 10.0
Solara Active Pharma Sciences Ltd 3,583 Cr. 736 774/422839 3460.00 %4.86 %0.13 % 10.0
Kwality Pharmaceuticals Ltd 3,712 Cr. 3,577 3,949/82945.5 3210.00 %23.9 %22.5 % 10.0
Dishman Carbogen Amcis Ltd 2,585 Cr. 164 307/128142 4260.00 %3.14 %1.58 % 2.00
Industry Average17,774.69 Cr1,258.9655.96211.600.38%26.16%16.59%6.06

All Competitor Stocks of Advanced Enzyme Technologies Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 142139147158161158155146169167186185172203190
Expenses 10095103107107102103104114122129124123140139
Operating Profit 424444515455514255465660496351
OPM % 29%32%30%32%33%35%33%29%33%27%30%33%29%31%27%
Other Income 977614-67108991020713
Interest 111111111111111
Depreciation 989999999101010101010
Profit before tax 404241485940494253435560586054
Tax % 31%24%29%27%28%25%28%21%27%38%26%25%26%24%28%
Net Profit 283229354230353339274045434539
EPS in Rs 2.632.872.583.083.742.533.052.943.372.373.573.873.803.843.31

Last Updated: September 26, 2026, 9:43 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 26, 2026, 9:43 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 239222293329391420444502529541624637746750
Expenses 189131155177226236241269327382418441515526
Operating Profit 5091138152165184203232203158206196230224
OPM % 21%41%47%46%42%44%46%46%38%29%33%31%31%30%
Other Income 11-33156962121334650
Interest 139849543334542
Depreciation 10991318212628353535374040
Profit before tax 2874118137139162179210171140188187233231
Tax % 23%31%35%32%33%28%26%28%28%26%27%28%25%
Net Profit 2151779394116133151124104137134174172
EPS in Rs 1.854.606.978.208.079.9511.5813.0910.709.4511.9211.7215.0714.82
Dividend Payout % 6%4%3%5%6%6%5%7%9%11%43%44%36%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)142.86%50.98%20.78%1.08%23.40%14.66%13.53%-17.88%-16.13%31.73%-2.19%29.85%
Change in YoY Net Profit Growth (%)0.00%-91.88%-30.20%-19.70%22.33%-8.75%-1.12%-31.41%1.75%47.86%-33.92%32.04%

Advanced Enzyme Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:11%
5 Years:7%
3 Years:6%
TTM:6%
Compounded Profit Growth
10 Years:10%
5 Years:0%
3 Years:3%
TTM:-8%
Stock Price CAGR
10 Years:Not available
5 Years:8%
3 Years:8%
1 Year:-25%
Return on Equity
10 Years:14%
5 Years:11%
3 Years:10%
Last Year:10%

Last Updated: September 4, 2025, 10:20 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: August 27, 2026, 1:30 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 222222222222222222222222
Reserves 1882564425376578179481,0661,2131,3021,3981,610
Borrowings 11510154673528233534473932
Other Liabilities 92716510291104153137142150151170
Total Liabilities 4174505837278059711,1461,2601,4111,5211,6111,834
Fixed Assets 287285421491495563601619649650679692
CWIP 578111010101522412251
Investments 0000111124121102360403480584
Other Assets 125158153226188275413524380427430507
Total Assets 4174505837278059711,1461,2601,4111,5211,6111,834
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 5493107116129141163122140141142157
Cash from Investing Activity + -15-10-60-60-124-43-272-286-65-89-72
Cash from Financing Activity + -36-63-65-2-43-39-26-48-26-59-73-70
Net Cash Flow 221-1854-386010975-17117-2015
Free Cash Flow 428897105116901439510294108105
CFO/OP 88%88%105%97%70%94%94%87%112%93%103%96%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow42.0088.0097.00105.00116.0090.00143.0095.00102.0094.00108.00105.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 496152555551616361685866
Inventory Days 387403358352339363361346402343375378
Days Payable 818968577846435660674041
Cash Conversion Cycle 356374342351315369379353404344393403
Working Capital Days -54-4337647729094116109102112
ROCE %12%25%36%31%25%24%22%22%15%12%15%13%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 45.92%43.62%43.50%43.02%42.95%42.92%43.08%43.08%43.08%43.04%43.26%43.25%
FIIs 22.27%22.54%23.01%12.03%12.63%12.57%11.90%23.45%25.41%25.85%25.50%26.70%
DIIs 6.49%6.98%7.56%8.08%8.02%8.17%8.19%8.45%6.41%5.51%5.41%4.77%
Public 25.34%26.88%25.95%36.87%36.40%36.31%36.82%25.00%25.09%25.62%25.85%25.28%
No. of Shareholders 72,64273,03468,64065,22266,75867,35165,32267,58969,63768,05166,19363,599
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
UTI MNC Fund 1,037,821 1.12 30.8N/AN/AN/A
ICICI Prudential ESG Exclusionary Strategy Fund 872,022 1.82 25.88N/AN/AN/A
Bank of India ELSS Tax Saver 38,876 0.08 1.15118,1512026-02-21 03:10:27-67.1%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 11.7211.929.4510.7013.09
Diluted EPS (Rs.) 11.7111.929.4510.6813.07
Cash EPS (Rs.) 15.2415.4012.4214.2016.10
Book Value[Excl.RevalReserv]/Share (Rs.) 127.00122.61114.84102.0092.25
Book Value[Incl.RevalReserv]/Share (Rs.) 127.00122.61114.84102.0092.25
Revenue From Operations / Share (Rs.) 56.9355.7948.3547.3544.92
PBDIT / Share (Rs.) 20.3321.5616.2718.5921.51
PBIT / Share (Rs.) 17.0618.4113.1315.4618.97
PBT / Share (Rs.) 16.7516.8012.5515.3018.83
Net Profit / Share (Rs.) 11.9712.259.2911.0713.56
NP After MI And SOA / Share (Rs.) 11.7211.929.4510.7013.08
PBDIT Margin (%) 35.7138.6433.6439.2647.89
PBIT Margin (%) 29.9733.0027.1632.6542.23
PBT Margin (%) 29.4130.1025.9632.3141.91
Net Profit Margin (%) 21.0321.9519.2123.3830.18
NP After MI And SOA Margin (%) 20.5821.3619.5322.5829.13
Return on Networth / Equity (%) 9.2210.068.5510.9815.06
Return on Capital Employeed (%) 12.5214.4010.9214.3119.53
Return On Assets (%) 8.088.687.429.4312.68
Long Term Debt / Equity (X) 0.010.010.010.010.01
Total Debt / Equity (X) 0.010.010.010.010.01
Asset Turnover Ratio (%) 0.400.420.330.320.38
Current Ratio (X) 9.097.619.3110.007.64
Quick Ratio (X) 7.476.227.718.006.25
Inventory Turnover Ratio (X) 4.171.141.231.301.32
Dividend Payout Ratio (NP) (%) 43.4941.9410.588.414.58
Dividend Payout Ratio (CP) (%) 34.0133.177.946.503.83
Earning Retention Ratio (%) 56.5158.0689.4291.5995.42
Cash Earning Retention Ratio (%) 65.9966.8392.0693.5096.17
Interest Coverage Ratio (X) 63.9582.3575.13115.72150.80
Interest Coverage Ratio (Post Tax) (X) 38.6652.9445.5869.9396.02
Enterprise Value (Cr.) 3081.993814.492529.422942.983729.91
EV / Net Operating Revenue (X) 4.846.114.685.567.43
EV / EBITDA (X) 13.5515.8213.9114.1615.52
MarketCap / Net Operating Revenue (X) 4.906.234.795.967.68
Retention Ratios (%) 56.5058.0589.4191.5895.41
Price / BV (X) 2.202.932.102.903.97
Price / Net Operating Revenue (X) 4.906.234.795.967.68
EarningsYield 0.040.030.040.030.03
Advertisements